investor relations | Intellia Therapeutics
The Investor Relations website contains information about Intellia Therapeutics's business for stockholders, potential investors, and financial analysts.
Total Visits
Avg. Visit Duration
Pages per Visit
Bounce Rate
Registration Date
| Month | Traffic |
|---|---|
| 2025-03 | 3.759 |
| 2025-04 | 4.159 |
| 2025-05 | 6.819 |
| Source | Traffic Share |
|---|---|
| search | 45.97% |
| direct | 37.74% |
| referrals | 10.05% |
| social | 5.06% |
| paid referrals | 1.08% |
| 0.07% |
| Region | Percentage |
|---|---|
| United States | 88.52% |
| United Kingdom | 5.67% |
| India | 2.87% |
| Australia | 1.48% |
| Canada | 1.45% |
| Keyword | Traffic | Volume | CPC |
|---|---|---|---|
| intellia therapeutics | 1,489 | 14,890 | $1.18 |
| intellia attr phase 3 pirmary endpoint | 0 | 0 | $0.00 |
| intellia proxy statement | 4 | 40 | $0.00 |
| intellia phase 1 2021 | 2 | 20 | $0.00 |
| how does intellia differentiate from silencers | 4 | 40 | $0.00 |